Former Fujifilm exec Weber joins Regenicin

John J. Weber, a former executive at Fujifilm Medical Systems USA, has joined Regenicin as a member of its board of directors and interim chief financial officer (CFO).

Weber brings more than 20 years of medical-related corporate, operational and financial management experience to Regenicin, a clinical-stage biotechnology company. He will help build the corporate structure as well as the sales and distribution platform for the company's future commercialization of PermaDerm, its tissue-engineered skin substitute intended to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and plastic surgery procedures.

Most recently, Weber served as executive vice president of Fujifilm from 2006 until his departure in 2009. His responsibilities included overseeing corporate activity with the exception of R&D, Regenicin said. From 1998 through 2006, he served as senior vice president of operations at Fujifilm, where he headed the transition of the company from a film distributor to a digital medical informatics company. From 1986 until 1998, he served as CFO at Fujifilm.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.